Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea · Delayed Price · Currency is KRW 3,955.00
-25.00 (-0.63%)
At close: Mar 31, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 43.16 billion as of March 31, 2026. Its market cap has decreased by -20.66% in one year.
Market Cap
43.16B
Enterprise Value
13.22B
Revenue
62.51B
Ranking
n/a
PE Ratio
6.63
Stock Price
3,955.00
Market Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 43.16B, an increase of 244.15%. That is a compound annual growth rate of 6.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 43.16B | -8.02% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinil Pharmaceutical | 67.35B |
| Kyung Nam Pharm | 61.97B |
| Jin Yang Pharmaceutical | 56.55B |
| RP Bio | 54.34B |
| Korea Arlico Pharm | 50.89B |
| Eagle Veterinary Technology Co.,Ltd | 48.04B |
| GeneBioTech Co. ,Ltd | 41.98B |
| HLscience | 38.04B |